“The rapid pace of science and technology advancements is making treatment decisions more complex,” said Emma McGuigan, senior managing director and Enterprise & Industry Technologies lead at ...
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) is positioned as a leader in the IDC MarketScape analysis of life science sales and marketing IT outsourcing services in 2022. The report — "IDC ...
Collaboration will bring embedded regulatory compliance and auditability to enterprise AI solutions for life sciences companies Accenture (NYSE: ACN) has invested, through Accenture Ventures, in ...
NEW YORK--(BUSINESS WIRE)-- Accenture (NYSE: ACN) has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions for leading biopharma organizations across ...
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has been named a Leader in an IDC Health Insights IDC MarketScape vendor assessment covering business process outsourcing (BPO) across the life ...
Salesforce recently pulled back the curtain on a plan to adapt its customer management and analytics software specifically for the use of life sciences companies, and several supporting roles in that ...
Pharma leaders who intentionally design human plus AI collaboration at the task level can change how their organizations show ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Accenture (NYSE: ACN) has invested, through Accenture Ventures, in Iridius, an enterprise AI infrastructure company that designs compliant-by-design AI solutions for highly regulated industries, ...
Collaboration will bring embedded regulatory compliance and auditability to enterprise AI solutions for life sciences companies The collaboration will combine Accenture’s deep industry knowledge and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results